Skip to main content
letter
. 2022 Mar 15;15:1899–1906. doi: 10.2147/JIR.S357758

Table 3.

Comparison Between Patients with High and Low NLR

Variable NLR≥2.54 (n=104) NLR<2.54 (n=63) P value
Gender 0.421
Male(%) 77(74%) 43(68%)
Female(%) 27(26%) 20(32%)
Age (years) 58(44, 74) 39(18, 53) <0.001***
Hypertension 24(23.1%) 4(6.3%) 0.009**
Diabetes mellitus 8(7.7%) 4(6.3%) 0.745
Active smoking 38(36.5%) 11(17.5%) 0.010*
No. (%) of organs involved
None 39(37%) 31(49%) 0.087
One 37(36%) 31(49%) 0.981
Two 21(20%) 1(2%) 0.012*
Three or more 7(7%) 0(0%) 0.017*
Cardiac involvement(%) 97(93%) 7(11%) 0.001**
Skin involvement(%) 60(48%) 5(8%) 0.031*
Pulmonary involvement(%) 19(18%) 8(13%) 0.563
Gastrointestinal involvement(%) 20(19%) 12(13%) 0.772
Cerebral involvement(%) 12(12%) 1(16%) 0.925
White cell count (10^9/L) 13.3(8.1, 19.5) 10.9(7.5, 16.9) 0.985
Absolute eosinophil count (10^9/L) 4.7(1.9, 9.0) 3.5(1.6, 7.9) 0.047*
Eosinophil percentage (%) 36.3(19.5, 57.8) 34.5(19.8, 48.7) 0.041*
Platelet count (10^9/L) 225.0(169.0, 285.5) 248.0(208.0, 298.5) 0.053
PLR 127.6(83.3, 207.4) 109.3(78.8, 161.2) 0.086
SII 570.1(335.7, 983.5) 368.8(239.0, 733.7) 0.111

Notes: Data are presented as number of cases and percentages (%) or median (p25, p75). *P<0.05; **P<0.01; ***P<0.001.

Abbreviations: NLR, neutrophil/lymphocyte ratio; PLR, platelet/lymphocyte ratio; SII, systemic immune/inflammatory index.